Hyperbaric Oxygen Therapy to Improve Autologous Fat Graft Intake in Irradiated Breast

Recruiting N/A Interventional Study
Breast Reconstruction Lipofilling Hyperbaric Oxygen Therapy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
16 (estimated)
Sponsor
University Hospital, Geneva · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if hyperbaric oxygen therapy (HBOT) enhances fat graft survival in lipofilling procedures in irradiated breast cancer patients. The main questions it aims to answer are: Does it improve fat graft survival ? Evaluate safety and tolerability of HBOT in this setting? Researchers will compare patient receiving HBOT to a control group without HBOT to see if.…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult (18 y.o. or more) female patients considered for lipofilling following breast reconstruction in an oncological setting which received radiation therapy on the affected breast. * Ability to provide informed consent, documented by signature Exclusion Criteria: * Pregnanc…
Contacts

Dominik André-Lévigne, MD, PhD

+41 (0)22 372 79 97

dlev@hug.ch

CONTACT

Matteo Scampa, MD

+41 (0)79 55 38 542

asmp@hug.ch

CONTACT